Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 May 26;374(21):2095.
doi: 10.1056/NEJMc1602599.

Postmenopausal Osteoporosis

Karl Michaëlsson  1 , Per Aspenberg  2
Affiliations
Comment

Postmenopausal Osteoporosis

Karl Michaëlsson et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

Comment in

  • Postmenopausal Osteoporosis.
    Black DM, Rosen CJ. Black DM, et al. N Engl J Med. 2016 May 26;374(21):2096-7. doi: 10.1056/NEJMc1602599. N Engl J Med. 2016. PMID: 27223157 No abstract available.

Comment on

References

    1. Black DM, Rosen CJ. Postmenopausal osteoporosis. N Engl J Med. 2016;374:254–62. - PubMed
    1. Schilcher J, Koeppen V, Aspenberg P, Michaëlsson K. Risk of atypical femoral fracture during and after bisphosphonate use. N Engl J Med. 2014;371:974–6. - PubMed
    1. Järvinen TL, Michaëlsson K, Jokihaara J, et al. Overdiagnosis of bone fragility in the quest to prevent hip fracture. BMJ. 2015;350:h2088. - PubMed
    1. Black DM, Schwartz AV, Ensrud KE, et al. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA. 2006;296:2927–38. - PubMed
    1. McCloskey E. A BMD threshold for treatment efficacy in osteoporosis? A need to consider the whole evidence base. Osteoporos Int. 2016;27:417–9. - PubMed

MeSH terms

Substances

Grants and funding